This preview shows page 1. Sign up to view the full content.
Unformatted text preview: problematic ethically? Why? 8. Pharmaceutical companies maintain that they are doing nothing wrong in commissioning articles for academic journals relating to drugs they produce. What arguments do they offer in supporting this controversial practice? How strong are these arguments? 9. Editors say they want disclosure, but if you do it, they scream, ghostwriter!says Art Gertel, who oversees medical writing at Beardworth Consulting Group in Flemington, N. J. Despite the cries for transparency, the journal editors still feel that theres an element of corruption if a medical writer is paid by a drug company. (p. 3) Is Mr. Gertels complaint valid? 10. Note the Eprex case on p. 4. Dr. Dodgson . . . says she didnt like the Eprex assignment but I had to earn a living. What principle does Dr. Dodgson seem to be using here to justify her actions? Is this a sound ethical principle?...
View Full Document
- Spring '07